Cite
The Rescue on Reperfusion Damage in Cerebral Infarction by Nelonemdaz (RODIN) Trial: Protocol for a Double-Blinded Clinical Trial of Nelonemdaz in Patients with Hyperacute Ischemic Stroke and Endovascular Thrombectomy.
MLA
Lee, Jin Soo, et al. “The Rescue on Reperfusion Damage in Cerebral Infarction by Nelonemdaz (RODIN) Trial: Protocol for a Double-Blinded Clinical Trial of Nelonemdaz in Patients with Hyperacute Ischemic Stroke and Endovascular Thrombectomy.” Journal of Stroke, vol. 25, no. 1, Jan. 2023, pp. 160–68. EBSCOhost, https://doi.org/10.5853/jos.2022.02453.
APA
Lee, J. S., Lee, J. S., Gwag, B. J., Choi, D. W., An, C. S., Kang, H. G., Song, T.-J., Ahn, S. H., Kim, C. H., Shin, D.-I., & Kwon, S. U. (2023). The Rescue on Reperfusion Damage in Cerebral Infarction by Nelonemdaz (RODIN) Trial: Protocol for a Double-Blinded Clinical Trial of Nelonemdaz in Patients with Hyperacute Ischemic Stroke and Endovascular Thrombectomy. Journal of Stroke, 25(1), 160–168. https://doi.org/10.5853/jos.2022.02453
Chicago
Lee, Jin Soo, Ji Sung Lee, Byoung Joo Gwag, Dennis W Choi, Chun San An, Hyun Goo Kang, Tae-Jin Song, et al. 2023. “The Rescue on Reperfusion Damage in Cerebral Infarction by Nelonemdaz (RODIN) Trial: Protocol for a Double-Blinded Clinical Trial of Nelonemdaz in Patients with Hyperacute Ischemic Stroke and Endovascular Thrombectomy.” Journal of Stroke 25 (1): 160–68. doi:10.5853/jos.2022.02453.